Differences in the growth of paired Ugandan isolates of Mycobacterium tuberculosis within human mononuclear phagocytes correlate with epidemiological evidence of strain virulence

Infection and Immunity

Volumn 74, Issue 12, 2006, Pages 6865-6876

  Theus, Sue A ^a   Cave, M Donald ^a   Eisenach, Kathleen ^a   Walrath, Jessica ^b,c   Lee, Hung ^b,c   Mackay, Wilma ^b   Whalen, Christopher ^b   Silver, Richard F ^b,c,d  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL GROWTH; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; MONONUCLEAR PHAGOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS; UGANDA;

CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; FAMILY CHARACTERISTICS; HUMANS; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; PHAGOCYTES; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TUBERCULOSIS; UGANDA; VIRULENCE;

EID: 33845506831     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00561-06     Document Type: Article

References (32)

1. Alland, D., G. E. Kalkut, A. R. Moss, R. A. McAdam, J. A. Hahn, W. Bosworth, E. Drucker, and B. R. Bloom. 1994. Transmission of tuberculosis in New York City-an analysis by DNA fingerprinting and conventional epidemiologic methods N. Engl. J. Med. 330:1710-1716.
2. Brock, I., K. Weldingh, T. Lillebaek, F. Follmann, and P. Andersen. 2004. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am. J. Respir. Crit. Care Med. 170:65-69.
3. Collins, F., and M. Smith. 1969. A comparative study of the virulence of Mycobacterium tuberculosis measured in mice and guinea pigs. Am. Rev. Respir. Dis. 100:631-639.
4. Filliol, L, A. Motiwala, M. Cavatore, W. Qi, M. Hazbon, M. Bobadilla del Valle, J. Fyfe, L. Garcia-Garcia, N. Rastogi, C. Sola, T. Zozio, M. Guerrero, C. Leon, J. Crabtree, S. Angiuoli, K. Eisenach, R. Durmaz, M. Joloba, A. Rendon, J. Sifuentes-Osornio, A. Ponce de Leon, M. Cave, R. Fleischmann, T. Whittam, and D. Alland. 2006. Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP set. J. Bacteriol. 188:759-772.
5. Guwatudde, D., M. Nakakeeto, E. C. Jones-Lopez, A. Maganda, A. Chiunda, R. D. Mugerwa, J. J. Ellner, G. Bukenya, and C. C. Whalen. 2003. Tuberculosis in household contacts of infectious cases in Kampala, Uganda. Am. J. Epidemiol. 158:887-898.
6. Guwatudde, D., S. Zalwango, M. R. Kamya, S. M. Debanne, M. I. Diasz, A. Okwera, R. D. Mugerwa, C. King, and C. C. Whalen. 2003. Burden of tuberculosis in Kampala, Uganda. Bull. W. H. O. 81:799-805.
7. Hanson, C. A., and L. B. Reichman, 1989. Tuberculosis skin testing and preventative therapy. Semin. Respir. Infect. 4:182-188.
8. Kamerbeek, J., L. Schouls, A. Kolk, M. van Agterveld, D. van Soolingen, S. Kuijper, A. Bunschoten, H. Molhuizen, R. Shaw, M. Goyal, and J. van Embden. 1997. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35:907-914.
9. Keane, J., H. Remhold, and H. Kronfeld. 2000. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J. Immunol. 164:2016-2020.
10. Laird, N., and J. Ware. 1982. Random effects models for longitudinal data. Biometrics 38:963-974.
11. Li, Q., C. C. Whalen, J. M. Albert, R. Larkin, L. Zukowski, M. D. Cave, and R. F. Silver. 2002. Differences in rate and variability of intracellular growth of a panel of Mycobacterium tuberculosis clinical isolates within a human monocyte model. Infect. Immun. 70:6489-6493.
12. Lopez, B., D. Aguilar, H. Orozco, M. Burger, C. Espitia, V. Ritacco, L. Barrera, K. Kremer, R. Hernandez-Pando, K. Huygen, and D. Van Soolingen. 2003. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin. Exp. Immunol. 133:30-37.
13. Manca, C., M. B. Reed, S. Freeman, B. Mathema, B. Kreiswirth, C. E. Barry III, and G. Kaplan. 2004. Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis. Infect. Immun. 72:5511-5514.
14. Manca, C., L. Tsenova, C. E. Barry III, A. Bergtold, S. Freeman, P. A. J. Haslett, J. M. Musser, V. H. Freedman, and G. Kaplan. 1999. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J. Immunol. 162:6740-6746.
15. Mazurek, G., J. Jereb, P. LoBue, M. Iademarco, B. Metchock, and A. Vernon. 2005. Guidelines for using the QuantiFERON-TB gold test for detection of Mycobacterium tuberculosis infection, United States. Morb. Mortal. Wkly. Rep. 54(RR15):49-55.
16. Mudido, P., D. Guwatudde, M. Nakakeeto, G. B. Bukenya, D. Nsamba, J. L. Johnson, R. D. Mugerwa, J. J. Ellner, and C. C. Whalen. 1999. The effect of bacille Calmette-Guerin vaccination at birth on tuberculin skin test reactivity in Ugandan children. Int. J. Tuberc. Lung Dis. 3:891-895.
17. North, R., and A. Izzo. 1993. Mycobacterial virulence: virulent strains of Mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity. J. Exp. Med. 177:1723-1733.
18. Pethe, K., D. Swenson, S. Alonso, J. Anderson, C. Wang, and D. Russell. 2004. Isolation of Mycobacterium tuberculosis mutants defective in the arrest of phagosome maturation. Proc. Natl. Acad. Sci. USA 101:13642-13647.
19. Pierce, C., R. Dubos, and M. Schaefer. 1953. Multiplication and survival of tubercle bacilli in the organs of mice. J. Exp. Med. 97:189-206.
20. Public Health Service. 1985. Public health mycobacteriology: a guide for the level III laboratory. Public Health Service, U. S. Department of Health and Human Services, Washington, D.C.
21. Silver, R., Q. Li, W. Boom, and J. Ellner. 1998. Lymphocyte-dependent inhibition of growth of virulent Mycobacterium tuberculosis H37Rv within human monocytes: requirement for CD4+ T cells in purified protein derivative-positive, but not in purified protein deriviative-negative subjects. J. Immunol. 160:2408-2417.
22. Silver, R. F., Q. Li, and J. J. Ellner. 1998. Expression of virulence of Mycobacterium tuberculosis within human monocytes: virulence correlates with intracellular growth and induction of tumor necrosis factor alpha but not with evasion of lymphocyte-dependent monocyte effector functions. Infect. Immun. 66:1190-1199.
23. Small, P. M., P. C. Hopewell, S. P. Singh, A. Paz, J. Parsonnet, D. C. Ruston, G. F. Schecter, C. L. Daley, and G. K. Schoolnik. 1994. The epidemiology of tuberculosis in San Francisco-a population-based study using conventional and molecular methods. N. Engl. J. Med. 330:1703-1709.
24. Steenken, J., and L. U. Gardner. 1946. History of H37 strain of tubercle bacillus. Am. Rev. Tuberc. 54:62-66.
25. Theus, S., M. Cave, and K. Eisenach. 2005. Intracellular macrophage growth rates and cytokines of Mycobacterium tuberculosis strains with different transmission dynamics. J. Infect. Dis. 191:453-460.
26. Theus, S. A., M. D. Cave, and K. D. Eisenach. 2004. Activated THP-1 cells: an attractive model for the assessment of intracellular growth rates of Mycobacterium tuberculosis isolates. Infect. Immun. 72:1169-1173.
27. van Embden, J., M. Cave, J. Crawford, J. Dale, K. Eisenach, B. Gicquel, P. Mermans, C. Martin, R. McAdam, T. Shinnick, and P. Small. 1993. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J. Clin. Microbiol. 31:406-409.
28. van Rie, A., R. Warren, M. Richardson, T. C. Victor, R. P. Gie, D. A. Enarson, N. Beyers, and P. D. van Helden. 1999. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N. Engl. J. Med. 341:1174-1179.
29. van Soolingen, D., L. Qian, P. E. de Haas, J. T. Douglas, H. Traore, F. Portaels, H. Z. Qing, D. Enkhsaikan, P. Nymadawa, and J. D. van Embden. 1995. Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia. J. Clin. Microbiol. 33:3234-3238.
30. Vergne, I., J. Chua, H. Lee, M. Lucas, J. Belisle, and V. Deretic. 2005. Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 102:4033-4038.
31. Zhang, M., J. Gong, Y. Lin, and P. Barnes. 1998. Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages. Infect. Immun. 66:794-799.
32. Zhang, M., J. Gong, Z. Yang, B. Samten, D. M. Cave, and P. F. Barnes. 1999. Enhanced capacity of a widespread strain of Mycobacterium tuberculosis to grow in human macrophages. J. Infect. Dis. 179:1213-1217.